161 related articles for article (PubMed ID: 32735108)
21. Targeted next-generation sequencing of well-differentiated rectal, gastric, and appendiceal neuroendocrine tumors to identify potential targets.
Park HY; Kwon MJ; Kang HS; Kim YJ; Kim NY; Kim MJ; Min KW; Choi KC; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Choe JY; Lee HK
Hum Pathol; 2019 May; 87():83-94. PubMed ID: 30851333
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Factors for Locoregional Recurrence in Neuroendocrine Tumors of the Rectum.
Tsang ES; McConnell YJ; Schaeffer DF; Yin Y; Speers CH; Kennecke HF
Dis Colon Rectum; 2018 Feb; 61(2):187-192. PubMed ID: 29337773
[TBL] [Abstract][Full Text] [Related]
23. The novel WHO 2010 classification for gastrointestinal neuroendocrine tumours correlates well with the metastatic potential of rectal neuroendocrine tumours.
Jernman J; Välimäki MJ; Louhimo J; Haglund C; Arola J
Neuroendocrinology; 2012; 95(4):317-24. PubMed ID: 22327359
[TBL] [Abstract][Full Text] [Related]
24. Clinical Outcomes of Patients with Small Rectal Neuroendocrine Tumors Treated Using Endoscopic Submucosal Resection with a Ligation Device.
Takita M; Sakai E; Nakao T; Kimoto Y; Ishii R; Konishi T; Ueno S; Kanda K; Negishi R; Muramoto T; Hashimoto H; Morikawa T; Matsuhashi N; Ohata K
Digestion; 2019; 99(1):72-78. PubMed ID: 30554202
[TBL] [Abstract][Full Text] [Related]
25. Short- and long-term outcomes of endoscopic resection of rectal neuroendocrine tumours: analyses according to the WHO 2010 classification.
Nakamura K; Osada M; Goto A; Iwasa T; Takahashi S; Takizawa N; Akahoshi K; Ochiai T; Nakamura N; Akiho H; Itaba S; Harada N; Iju M; Tanaka M; Kubo H; Somada S; Ihara E; Oda Y; Ito T; Takayanagi R
Scand J Gastroenterol; 2016; 51(4):448-55. PubMed ID: 26540372
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the factors affecting lymph node metastasis and the prognosis of rectal neuroendocrine tumors.
Li P; Wu F; Zhao H; Dou L; Wang Y; Guo C; Wang G; Zhao D
Int J Clin Exp Pathol; 2015; 8(10):13331-8. PubMed ID: 26722537
[TBL] [Abstract][Full Text] [Related]
27. The clinical significance of neuroendocrine differentiation in T3-T4 node-negative colorectal cancer.
Cho YB; Yang SS; Lee WY; Song SY; Kim SH; Shin HJ; Yun SH; Chun HK
Int J Surg Pathol; 2010 Jun; 18(3):201-6. PubMed ID: 19372085
[TBL] [Abstract][Full Text] [Related]
28. Clinical characteristics, risk factors and outcomes of asymptomatic rectal neuroendocrine tumors.
Ko SH; Baeg MK; Ko SY; Jung HS
Surg Endosc; 2017 Oct; 31(10):3864-3871. PubMed ID: 28078467
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for lymph node metastasis in duodenal neuroendocrine tumors: A retrospective, single-center study.
Park SG; Lee BE; Kim GH; Park JW; Lee MW; Kim SJ; Choi CW; Lee S; Park DY
Medicine (Baltimore); 2019 Jun; 98(23):e15885. PubMed ID: 31169696
[TBL] [Abstract][Full Text] [Related]
30. Recurrence pattern and surveillance strategy for rectal neuroendocrine tumors after endoscopic resection.
Chung HG; Goh MJ; Kim ER; Hong SN; Kim TJ; Chang DK; Kim YH
J Gastroenterol Hepatol; 2021 Apr; 36(4):968-973. PubMed ID: 32864790
[TBL] [Abstract][Full Text] [Related]
31. Risk Factors for Lymph Node Metastasis of Rectal Neuroendocrine Tumor and Its Prognostic Impact: A Single-Center Retrospective Analysis of 195 Cases with Radical Resection.
Hiyoshi Y; Daitoku N; Mukai T; Nagasaki T; Yamaguchi T; Akiyoshi T; Yasue C; Chino A; Saito S; Takamatsu M; Fukunaga Y
Ann Surg Oncol; 2023 Jul; 30(7):3944-3953. PubMed ID: 36935432
[TBL] [Abstract][Full Text] [Related]
32. [Analysis of clinicopathological features of intestinal neuroendocrine neoplasms].
Gao W; Liu SM; Lu HZ; Liang J; Yuan YL; Liu XY
Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):450-6. PubMed ID: 22967448
[TBL] [Abstract][Full Text] [Related]
33. Extramural perineural invasion in pT3 and pT4 rectal adenocarcinoma as prognostic factor after preoperative chemoradiotherapy.
Lino-Silva LS; Salcedo-Hernández RA; España-Ferrufino A; Ruiz-García EB; Ruiz-Campos M; León-Takahashi AM; Meneses-García A
Hum Pathol; 2017 Jul; 65():107-112. PubMed ID: 28526604
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of Pathologic Prognostic Factors in Neuroendocrine Tumors of the Small Intestine.
Polydorides AD; Liu Q
Am J Surg Pathol; 2022 Apr; 46(4):547-556. PubMed ID: 35192293
[TBL] [Abstract][Full Text] [Related]
35. A simple and practical index predicting the prognoses of the patients with well-differentiated pancreatic neuroendocrine neoplasms.
Liu B; Kudo A; Kinowaki Y; Ogura T; Ogawa K; Ono H; Mitsunori Y; Ban D; Tanaka S; Akashi T; Tanabe M
J Gastroenterol; 2019 Sep; 54(9):819-828. PubMed ID: 30863885
[TBL] [Abstract][Full Text] [Related]
36. Characteristics and long-term prognosis of patients with rectal neuroendocrine tumors.
Chi Y; Du F; Zhao H; Wang JW; Cai JQ
World J Gastroenterol; 2014 Nov; 20(43):16252-7. PubMed ID: 25473180
[TBL] [Abstract][Full Text] [Related]
37. Chromogranin A predicts survival for resected pancreatic neuroendocrine tumors.
Shanahan MA; Salem A; Fisher A; Cho CS; Leverson G; Winslow ER; Weber SM
J Surg Res; 2016 Mar; 201(1):38-43. PubMed ID: 26850182
[TBL] [Abstract][Full Text] [Related]
38. Clinical and prognostic features of rectal neuroendocrine tumors.
Weinstock B; Ward SC; Harpaz N; Warner RR; Itzkowitz S; Kim MK
Neuroendocrinology; 2013; 98(3):180-7. PubMed ID: 24080744
[TBL] [Abstract][Full Text] [Related]
39. Clinical outcomes of endoscopic mucosal resection for rectal neuroendocrine tumor.
Kim J; Kim JH; Lee JY; Chun J; Im JP; Kim JS
BMC Gastroenterol; 2018 Jun; 18(1):77. PubMed ID: 29866049
[TBL] [Abstract][Full Text] [Related]
40. Long-term prognosis of an endoscopically treated rectal neuroendocrine tumor: 10-year experience in a single institution.
Sung HY; Kim SW; Kang WK; Kim SY; Jung CK; Cho YK; Park JM; Lee IS; Choi MG; Chung IS
Eur J Gastroenterol Hepatol; 2012 Aug; 24(8):978-83. PubMed ID: 22647741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
